Status: Recruiting
Randomized Double-Blind Trial on Safety and Efficacy of Nanordica Advanced Antibacterial Wound Dressing for Diabetic Foot Ulcer
This clinical trial evaluates the safety and efficacy of the Nanordica Advanced Antibacterial Wound Dressing (AAWD) in patients suffering from diabetic foot ulcers. At least 170 participants will be randomly allocated to be treated either with AAWD or Aquacel Ag+ Extra wound dressing for a 4-week active phase (intervention) followed by an 8-week standard of care period.
Participants needed: 170
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Nanordica Medical OUUpdated: Aug 27, 2025Locations: 11
Eligibility criteria
Voluntary, written informed consent obtained prior to any study related activiti... [+5]
Ssystemic or topical antibiotic therapy within 7 days before the enrolment. [+8]